Coherent Market Insights published a business research report on Biopharmaceutical and Biomedicine Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. Biopharmaceutical and Biomedicine Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/18
Biopharmaceuticals are drugs manufactured or extracted from biological sources. They contain variety of products, such as blood factors, colony stimulating factor, interferon, erythropoietin, human growth hormone, recombinant human insulin, vaccines, and monoclonal antibodies. At present, biopharmaceuticals account for over one-fifth of the pharmaceutical industry, and the share of biopharmaceuticals is expected to increase in the near future due to its advantages over fully synthesized pharmaceuticals. Ability to cure the disease, high effectiveness, and fewer side effects are some of the major advantages of biopharmaceuticals.
Frequent approvals/launches and robust pipeline of biopharmaceutical products is expected to augment the growth of the global biopharmaceutical and biomedicine market over the forecast period. For instance in 2017, Johnson and Johnson received the Food and Drug Administration (FDA) approval for Tremfya (Guselkumab) to treat moderate to severe plaque psoriasis.
In 2017, Sanofi received FDA approval for a rapid-acting insulin, Admelog, designed for the management of blood sugar levels. In 2017, GlaxoSmithKline received FDA approval for its shingles vaccine, Shingrix, for the prevention of shingles (herpes zoster) in adults aged 50 years and above. Moreover, in 2017, Spark Therapeutics, Inc. received FDA approval for Luxturna, indicated for the treatment of inherited retinal disease (IRD). It is the first approved adeno-associated virus (AAV) vector gene therapy in the U.S.
Furthermore, players in the market are adopting various strategies, such as acquisitions and collaboration, to expand their product portfolio. For instance, in February 2018, LGC Limited acquired Lucigen Corporation to expand its portfolio of NGS kits, competent cells, enzymes, and cloning systems. In February 2018, ImmunoQure and Servier announced the establishment of an exclusive partnership to develop a therapeutic autoantibody neutralizing interferon-alpha. Moreover, in 2018, Wuxi Biologics and Adagene collaborated to discover and develop novel antibody therapeutics. Whereas, in 2017, Omicia acquired Spiral Genetics to strengthen its position in the global market and expand its bio-informatics tools portfolio.
Increase in funding for the research and development of new biopharmaceuticals is expected to boost the growth of the global biopharmaceutical and biomedicine market over the forecast period. For instance, in 2017, the Government of India planned to invest US$ 250 million to develop biological drugs in India. Moreover, the Johns Hopkins University School of Medicine (JHUSM) and the University of Liverpool teamed up to develop new nanomedicines for HIV, and received around US$ 3 million from the National Institutes of Health to continue research and development and generate new technologies.
High cost of biopharmaceutical and biomedicine, complex manufacturing process, and dearth for skilled scientists are some major factors expected to hamper the global biopharmaceutical and biomedicine market growth.
Key players active in the global biopharmaceutical and biomedicine market are Amgen Inc., Novartis AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Sanofi S.A., Pfizer, Inc., Eli Lilly and Company, Novo Nordisk A/S, AbbVie Inc., Bristol – Myers Squibb, Qiagen N.V., Affimed N.V., Celgene Corporation, and NanoString Technologies, Inc., among others.
Buy This Report With USD 2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/18
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Biopharmaceutical and Biomedicine Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Biopharmaceutical and Biomedicine Industry Impact
Chapter 2 Global Biopharmaceutical and Biomedicine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biopharmaceutical and Biomedicine (Volume and Value) by Type
2.3 Global Biopharmaceutical and Biomedicine (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Biopharmaceutical and Biomedicine Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Biopharmaceutical and Biomedicine Market Analysis
Chapter 6 East Asia Biopharmaceutical and Biomedicine Market Analysis
Chapter 7 Europe Biopharmaceutical and Biomedicine Market Analysis
Chapter 8 South Asia Biopharmaceutical and Biomedicine Market Analysis
Chapter 9 Southeast Asia Biopharmaceutical and Biomedicine Market Analysis
Chapter 10 Middle East Biopharmaceutical and Biomedicine Market Analysis
Chapter 11 Africa Biopharmaceutical and Biomedicine Market Analysis
Chapter 12 Oceania Biopharmaceutical and Biomedicine Market Analysis
Chapter 13 South America Biopharmaceutical and Biomedicine Market Analysis
Chapter 14 Company Profiles and Key Figures in Biopharmaceutical and Biomedicine Business
Chapter 15 Global Biopharmaceutical and Biomedicine Market Forecast (2021-2027)
Chapter 16 Conclusions
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/18
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Press Release: https://www.coherentmarketinsights.com/press-release/biopharmaceutical-and-biomedicine-market-to-surpass-us-8000-bn-threshold-by-2025-166